Tubulis, a leading biotechnology company focused on developing next-generation antibody-drug conjugates (ADCs), today announced the successful closing of a €308 million (USD 361 million) Series C financing round — one of the largest private financings in the European biotech sector…
insitro, a leading machine learning–driven drug discovery and development company, has announced the next phase of its ongoing collaboration with Bristol Myers Squibb (NYSE: BMY) to develop novel therapeutics for amyotrophic lateral sclerosis (ALS). The collaboration extension deepens the partnership’s…
Verily announced a multi-year strategic collaboration with UCHealth, the University of Colorado Anschutz Medical Campus, and RefinedScience aimed at transforming the use of biomedical data and redefining how patient care is delivered. This partnership leverages Verily’s expertise in healthcare technology…
Ascribe Bio, a pioneer in natural crop protection technologies, announced the successful closing of a $12 million oversubscribed Series A financing round, co-led by Corteva, through its Corteva Catalyst platform, and Acre Venture Partners. The funding round also saw participation…
Enpro Inc., a leading industrial technology company, has announced definitive agreements to acquire two strategically aligned companies — AlpHa Measurement Solutions and Overlook Industries — for a combined total of approximately $280 million in cash. These acquisitions mark a significant…
Infleqtion, a global leader in neutral atom-based quantum technology, has announced a strategic partnership with Silicon Light Machines (SLM), a Silicon Valley innovator in micro-electro-mechanical systems (MEMS). This collaboration aims to integrate SLM’s Displacement Phase Modulator (DPM™) technology into Infleqtion’s…
Expedition Therapeutics, a biotechnology company focused on developing treatments for novel inflammatory and respiratory diseases, today announced the completion of an oversubscribed and upsized $165 million Series A financing. The round was co-led by Sofinnova Investments and Novo Holdings, with…
Charles River Laboratories International, Inc. and Toxys have announced a strategic collaboration to expand access to ReproTracker®, a cutting-edge, human stem cell-based in vitro assay designed to identify developmental toxicity hazards in pharmaceuticals and chemicals. The partnership aims to accelerate…
Kernal Biologics, Inc., a venture-backed TechBio company transforming the treatment landscape through mRNA-based in vivo cell programming, announced it has been awarded up to $48 million in funding from the Advanced Research Projects Agency for Health (ARPA-H). The award comes…
Membrion, a pioneering ceramic desalination membrane innovator, has successfully completed a $20 million Series B1 funding round, marking a significant milestone in its mission to revolutionize industrial water management. The round was anchored by leading climate-tech and materials investors, including…